{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:08:56Z","timestamp":1758816536095},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Activation of muscarinic receptors in the brain antagonizes the actions of cocaine, blocking both its discriminative stimulus and reinforcing properties. Pilocarpine is a nonselective muscarinic agonist that is used clinically, but has not been well characterized for its actions during cocaine-reinforced behavior. This study evaluated its effects on cocaine-reinforced and food-reinforced behaviors in rats, using the cholinesterase inhibitor tacrine as a comparator. Intraperitoneal pilocarpine or tacrine at doses of 1.0 mg\/kg or more attenuated self-administration of low-dose cocaine (0.1 mg\/kg injection) but also increased oral movements. Pilocarpine was less potent than tacrine in decreasing responding supported by low or intermediate amounts of liquid food. Combined treatment with pilocarpine and tacrine was more effective than either compound alone in attenuating self-administration of intermediate-dose cocaine. At a low (0.66 mg\/kg) dose which did not modify reinforced responding, pilocarpine increased nonspecific behavior (sniffing, rearing, and activity) in cocaine-reinforced but not in food-reinforced animals; with greater doses increasing cholinergic or gastrointestinal signs. These effects were most consistently correlated with changes in reinforcement in rats responding for cocaine relative to food-reinforced animals. Overall, pilocarpine exhibited modest selectivity for attenuating self-administration of low-dose cocaine without affecting a nondrug reinforcer.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000472","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T01:47:56Z","timestamp":1549417676000},"page":"478-489","source":"Crossref","is-referenced-by-count":3,"title":["The muscarinic agonist pilocarpine modifies cocaine-reinforced and food-reinforced responding in rats: comparison with the cholinesterase inhibitor tacrine"],"prefix":"10.1097","volume":"30","author":[{"given":"Kenneth W.","family":"Grasing","sequence":"first","affiliation":[{"name":"Substance Abuse Research Laboratory, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"},{"name":"Department of Medicine, Division of Clinical Pharmacology, University of Kansas School of Medicine, Kansas City, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Biological Science, Florida State University, Tallahassee, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Y.","family":"Idowu","sequence":"additional","affiliation":[{"name":"Substance Abuse Research Laboratory, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/npp.2010.18","article-title":"Altered neural cholinergic receptor systems in cocaine-addicted subjects.","volume":"35","author":"Adinoff","year":"2010","journal-title":"Neuropsychopharm"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02257673","article-title":"The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer\u2019s disease.","volume":"5","author":"Alhainen","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2201\/nonlin.003.01.002","article-title":"The inverted \u2018u-shaped\u2019 dose\u2013effect relationships in learning and memory: modulation of arousal and consolidation.","volume":"3","author":"Baldi","year":"2005","journal-title":"Nonlinearity Biol Toxicol Med"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/17425255.4.10.1333","article-title":"Systemic pilocarpine for treatment of xerostomia.","volume":"4","author":"Berk","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0306-4522(03)00378-6","article-title":"Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine.","volume":"120","author":"Berlanga","year":"2003","journal-title":"Neuroscience"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuron.2013.12.027","article-title":"Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling.","volume":"81","author":"Chuhma","year":"2014","journal-title":"Neuron"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: first drug approved for Alzheimer\u2019s disease.","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann Pharmacother"},{"key":"R9-20230910","first-page":"378","article-title":"Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1\u2013m5) expressed in baculovirus-infected insect cells.","volume":"274","author":"Dong","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-3057(97)00108-1","article-title":"Inhibition of grooming by pilocarpine differs in high- and low-yawning sublines of Sprague-Dawley rats.","volume":"58","author":"Eguibar","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.108.145219","article-title":"Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.","volume":"328","author":"Figueroa","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-20230910","first-page":"183","article-title":"Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer\u2019s disease and schizophrenia.","volume":"10","author":"Foster","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/dmd.110.035964","article-title":"Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.","volume":"39","author":"Goh","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2016.06.022","article-title":"A threshold model for opposing actions of acetylcholine on reward behavior: molecular mechanisms and implications for treatment of substance abuse disorders.","volume":"312","author":"Grasing","year":"2016","journal-title":"Behav Brain Res"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-003-1442-x","article-title":"A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats.","volume":"168","author":"Grasing","year":"2003","journal-title":"Psychopharmacology"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-007-0944-3","article-title":"Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats.","volume":"196","author":"Grasing","year":"2008","journal-title":"Psychopharmacology"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FBP.0b013e3283428cd8","article-title":"Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.","volume":"22","author":"Grasing","year":"2011","journal-title":"Behav Pharmacol"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2015.04.003","article-title":"Enduring effects of tacrine on cocaine-reinforced behavior: analysis by conditioned-place preference, temporal separation from drug reward, and reinstatement.","volume":"97","author":"Grasing","year":"2015","journal-title":"Pharmacol Res"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2017.11.018","article-title":"Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer\u2019s disease.","volume":"136","author":"Lebois","year":"2017","journal-title":"Neuropharmacology"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1371\/journal.pone.0000698","article-title":"Intense sweetness surpasses cocaine reward.","volume":"2","author":"Lenoir","year":"2007","journal-title":"PLoS ONE"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1440-1827.1999.00977.x","article-title":"Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.","volume":"49","author":"Oda","year":"1999","journal-title":"Pathol Int"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(01)00824-X","article-title":"Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.","volume":"415","author":"Ogura","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R23-20230910","first-page":"342","article-title":"Effects of pilocarpine hydrochloride and cevimeline on submandibular\/sublingual salivation in rat xerostomia model produced by X-ray irradiation.","volume":"53","author":"Omori","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"R24-20230910","first-page":"171","article-title":"Absorption, distribution and excretion of 14C-pilocarpine following oral administration to rats.","volume":"54","author":"Omori","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(00)00442-8","article-title":"Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice.","volume":"402","author":"Rasmussen","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejmech.2017.08.013","article-title":"Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: design, synthesis and biological evaluation.","volume":"139","author":"Reddy","year":"2017","journal-title":"Eur J Med Chem"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J","article-title":"Some comments on frequently used multiple endpoint adjustment methods in clinical trials.","volume":"16","author":"Sankoh","year":"1997","journal-title":"Stat Med"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/jpet.109.162057","article-title":"Attenuation of cocaine\u2019s reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.","volume":"332","author":"Thomsen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(94)90906-7","article-title":"Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine.","volume":"180","author":"Wilson","year":"1994","journal-title":"Neurosci Lett"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-199549010-00010","article-title":"Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.","volume":"49","author":"Wiseman","year":"1995","journal-title":"Drugs"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.1193771","article-title":"Cholinergic interneurons control local circuit activity and cocaine conditioning.","volume":"330","author":"Witten","year":"2010","journal-title":"Science"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2017.06.010","article-title":"Broad analgesic activity of a novel, selective M1 agonist.","volume":"123","author":"Wood","year":"2017","journal-title":"Neuropharm"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.3064-16.2017","article-title":"Cholinergic interneurons underlie spontaneous dopamine release in nucleus accumbens.","volume":"37","author":"Yorgason","year":"2017","journal-title":"J Neurosci"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:06:23Z","timestamp":1694333183000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000472","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}